glp 1 for alcohol GLP‐1 Receptor Agonists Treating Use Disorder: A Critical Review - Woo - 2026 - Alcohol, Clinical and Experimental Research How GLP-1 Drugs Are Impacting

The medication manages Type 2 diabetes rather than curing it

Our attorneys have recovered over $900 million in compensation for our valued clients since 2000 alone (see disclaimer below), and were proud to be named a Best Family-Run Law Firm in 2025 by NC Lawyers Weekly

Chronic stress drives weight regain Cortisol, the primary stress hormone, promotes fat storage, particularly visceral fat around the midsection

While both medications are primarily prescribed for type 2 diabetes, the synergistic weight loss effect is a significant benefit

NEW - Blue Shield will launch three PPO Savings Plans offering expanded weight loss drug coverage in 2027: Full PPO Savings Embedded Deductible 3400 100% with Enhanced+ Rx Full PPO Savings Two-Tier Embedded Deductible 1700/3400/3400 90/60 with Enhanced+ Rx NOTE: Weight loss drugs under these plans are covered with prior authorization for BMI 30 or 27 with certain weight-related conditions, lowering the requirement from the previous BMI of 40

Both are once-weekly GLP-1 receptor agonists approved for type 2 diabetes, but they are different molecules with different efficacy and side effect profiles